American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
David G. Pfister(Memorial Sloan Kettering Cancer Center), Gregory T. Wolf(University of Michigan–Ann Arbor), William M. Mendenhall(American Society of Clinical Oncology), David J. Adelstein(Cleveland Clinic), Arlene A. Forastiere(Johns Hopkins University), Susan G. Fisher(American Society of Clinical Oncology), Scott A. Laurie(Ottawa Hospital), Snehal G. Patel(American Society of Clinical Oncology), Marshall R. Posner(University of Maryland, Baltimore), Michael Schwartz(American Society of Clinical Oncology), Jean‐Louis Lefebvre(American Society of Clinical Oncology), Louis B. Harrison(American Society of Clinical Oncology), Marcy A. List(American Society of Clinical Oncology), Gregory S. Weinstein(University of Pennsylvania), Bernard O’Malley(American Society of Clinical Oncology), Gary L. Clayman(The University of Texas MD Anderson Cancer Center), K. Kian Ang(The University of Texas MD Anderson Cancer Center), Nancy E. Leupold(American Society of Clinical Oncology)
Cited by 504
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
|Head & Neck|2005|1.8k
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
|Journal of Clinical Oncology|2003|1.4k